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Abstract Fourteen novel pterostilbene (1) and 3′-methoxy
pterostilbene (2) Mannich base derivatives (3–16) were syn-
thesized via the microwave-assisted Mannich reaction of
1 or 2 with various secondary amines and formaldehyde.
The regioselectivity of the reaction occurred preferentially
at C-3′(and /or C-5′) position of the B-ring of stilbene. The
biological testing results showed that all the target com-
pounds exhibit antiproliferative activity against Hela cells
from IC50 = 22.5–65.3µM. Compounds 1–3, 7, 11–13, and
16 displayed higher (lower IC50 values) activity than the pos-
itive control cisplatin (IC50 = 41.3µM).
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Introduction
Pterostilbene (trans-3,5-dimethoxy-4′-hydroxystilbene, 1), a
naturally occurring dimethylether analog of resveratrol, was
first isolated from P. Santalinus (red sandalwood) and it is
also found in several types of berries and grapes [1]. Pteros-
tilbene has been shown to have a cancer chemopreventive
effect similar to that of resveratrol and it is cytotoxic to a
variety of tumor cell types, such as human gastric carcinoma
cells [2], human prostate cancer cells [3], and lung cancer
cells [4]. 3′-Methoxy pterostilbene (2), a naturally occurring
homolog of pterostilbene, was isolated from Sphaerophysa
salsula [5] and showed higher cytotoxic activities on some
cancer cells than resveratrol [6].
Biological activity studies have shown that the develop-
ment of structural analogs of antitumor agents possessing
basic nitrogen atommoiety is of great value [7,8]. Anticancer
studies using several classes of polyaromatic antitumour
agents indicate that the introduction of a nitrogen-containing
side chain increases significantly the biological activity
and potency of the parent compounds. For example, it has
been shown that the presence of the nitrogen moiety in
flavopiridol, a synthetic nitrogen-containing flavonoid with
antitumor activity against various tumor cell lines, is crit-
ical for its antitumor effect [9]. The Mannich reaction is
a commonly used way to introduce nitrogenous moieties,
such as aminoalkyl group to phenols. The modification of
an aminoalkyl side chain in aromatic substrates permits
to increase significantly the biological potency of bioac-
tive molecules due to the greater number of molecular sites
for electrophilic attack by cellular constituents, as well as
due to the cascade effect of preferential chemosensitization
when compared with parent compounds [10]. Furthermore,
Mannich bases have been associated with increased water
solubility [11].
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Scheme 1 Synthesis of pterostilbene and 3′-methoxy pterostilbene Mannich base derivatives (3–16)
Resveratrol has been the subject of numerous investiga-
tions, and its cancer chemopreventive activity has been fully
demonstrated [12]. Prompted by the close structural similar-
ity of pterostilbene and resveratrol, as well as the current
high interest in the development of a pterostilbene-based
therapeutic [13,14], we decided to synthesize two series of
fourteen pterostilbene and 3′-methoxy pterostilbene Man-
nich base derivatives to be evaluated for their antiproliferative
activity against human cervical carcinoma Hela cells by the
standard CCK-8 assay.
Results and discussion
The synthetic route used for the construction of novel
pterostilbene and 3′-methoxy pterostilbene Mannich base
derivatives (3–16) is shown in Scheme 1. Pterostilbene
(1) and 3′-methoxy pterostilbene (2) were synthesized by
O-methylation, reduction, chlorination, Arbuzov rearrange-
ment, and Wittig reaction using commercially available 3,5-
dihydroxybenzoic acid, 4-hydroxybenzaldehyde, or vanillin
as startingmaterial as described previously by our group [15].
Our strategy for the synthesis of the C-aminomethylated
derivatives relied upon the electrophilic substitution at C-3′
and/or C-5′ of the stilbene B-ring. This was achieved
by the Mannich reaction of 1 and 2 with formaldehyde
and secondary amines in methanol, introducing a dialky-
laminomethyl group in the ortho- position of the phenolic
group. The general conditions of the Mannich reaction for
the phenol compounds are based on the substrate, the amine,
and formaldehyde ratio in alcohol with prolonged heating. It
was reported that microwave irradiation can be used for the
Mannich reaction because of the considerable advantages
over conventional heating, such as substantial rate enhance-
ment cleaner reaction and improvement in yield [16,17].
In our case, pterostilbene (1) or 3′-methoxypterostilbene
(2), formaldehyde, and secondary amines in a 1:1.2:1.2
ratio, respectively, were stirred under microwave irradia-
tion (600 W) for 0.5–2 h in methanol to afford the C-
aminomethylated derivatives 3–16. The Mannich reaction of
pterostilbene (1) with methylpiperazine would lead to a dif-
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Table 1 Half-inhibitory concentration [IC50(µM)]of compounds 1–16
on the Hela cells
Compounds IC50(µM) Compounds IC50(µM)
1 28.5 10 41.6
2 23.0 11 35.4
3 23.3 12 38.4
4 41.8 13 387
5 42.5 14 43.0
6 50.4 15 65.3
7 28.3 16 36.7
8 57.1 cisplatina (DDP) 41.3
9 50.5
a cisplatin (DDP) was employed as positive control
ferent product at different reaction times where the product
was a mono-substituted product (compound 6, 0.5 h of reac-
tion time) or a double-substituted product (compound 8, 2 h
of reaction time).
The structures of all synthesized Mannich base were con-
firmedby 1HNMR,13 CNMR, andMSanalysis. The 1HNMR
spectra of compounds 3–9 clearly indicate the absence of the
of H-3′ proton signal at δ 6.28 (and H-5′ proton for com-
pounds 8, 9) in the B-ring of pterostilbene (1). Similarly, the
H-5′ proton at δ 6.91 of 3′-methoxy pterostilbene (2) in the
B-ring disappeared for compounds 10–16. The signal at δ
3.60–4.10 indicated the presence of the aminomethyl group
at C-3′ (or C-5′) position of compounds 3–16.
The antiproliferative activity of the pterostilbene (1),
3′-methoxypterostilbene (2), and the Mannich base deriv-
atives 3–16 was assessed using the CCK-8 [2H-tetrazolium,
5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2-(4-
nitrophenyl) inner salt, sodium salt (1:1)] assay using the
human cervical carcinoma Hela cell line. The results are
shown in Table 1. The dose-response curves for the CCK-8
assay of compounds 1, 2, 3 and 7 on Hela cells proliferation
are shown inFig. 1.Cisplatin (DDP)was used as positive con-
trol. The results show that all the test compounds exhibitmod-
erate to potent antiproliferative activity against Hela cells.
In the series of pterostilbene Mannich bases, our data
showed that compound 3, characterized by a dimethy-
laminomethyl group in the C-3′ position, was found to
have an increase in antiproliferative activity (IC50 =
23.3µM) when compared with parent compound pterostil-
bene (1, IC50 = 28.5µM). Compound 7 (IC50 = 28.3µM),
which contains a pyrrolidin-1-ylmethyl group substituent on
the C-3′ position, presented with potency similar to that
of parent compound pterostilbene (1). Compounds 1, 3,
and 7 (IC50 range 23.3–28.5 µM) showed more potent
antiproliferative activity against Hela cells than the positive
control cisplatin (DDP) (IC50 = 41.3µM). In the series of
3′-methoxypterostilbene Mannich bases, although the intro-
duction of a dialkylaminomethyl group did not increase the
activity compared to its parent compound 2, compounds 11,
12, 13 and 16 exhibited some antiproliferative activity on
Hela cells (IC50 range of 35.4–38.7µM) being slightly more
potent than cisplatin (DDP) (IC50 = 41.3µM).
The preliminary structure–activity relationship analysis
revealed that pterotilbene (1) has amoderate antiproliferative
activity on Hela cells. The introduction of smaller methoxy
or dimethylaminomethyl side chains into the 3′-position of
1 was to increase biological activity, and the introduction
of larger dialkylaminomethyl side chain into 3′-position of 1
was to decrease the activity. Based on these observations, the
methoxy and dimethylaminomethyl groups were selected as
suitable substituents at the 3′-position of 1. The introduction
of all dialkylaminomethyl side chain into 5′-position of 3′-
methoxy pterostilbene (2) was to decrease the activity. As the
antiproliferation assay was carried out in vitro, the inhibitory
effect on Hela cell variance among these compounds could
be attributed to the hydrophobicity and permeability changes
resulting from different substituents and position of side
chains in pterostilbene (1) .
Conclusion
In Summary, 14 newpterostilbene (1) and 3′-methoxy pteros-
tilbene (2) Mannich base derivatives 3–16 were synthesized
through a microwave-assistedMannich reaction strategy. All
the compounds were tested for their antiproliferative activity
againstHela cells using the standardCCK-8 assay; the results
indicating that compounds 1, 2, 3, 7, 11, 12, 13 and 16 were
slightly more potent than anticancer drug cisplatin (DDP).
The pterostilbene skeleton can serve as a promising struc-
tural template for the development of novel antiproliferative
agents deserving further investigation.
Experimental
General information
Melting points were measured on an XRC-I apparatus and
were uncorrected. Microwave reactions were performed
using an XH-MC-1 microwave reactor (50–900 W) (Bei-
jing Xianghu Science and Technology Development Co.,
China). 1H NMR and 13C NMR spectra were recorded
on a Bruker AM-400 instrument, using tetramethylsilane
as internal standard (s single; d doublet; t triplet; q quar-
let; m multiplet), chemical shifts (δ) in ppm, and coupling
constants (J ) in Hz. Mass spectra were recorded using a
VG Autospec-3000 and a ZA-BHS spectrometer (ESI or
EI ionization method). Pterostilbene (1) and 3′-methoxy
pterostilbene (2) were synthesized and purified according
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Fig. 1 Dose-response curve of
compounds 1, 2, 3 and 7 on
Hela cell proliferation assay
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to our published procedure [15]. Formaldehyde, secondary
amines, methanol, ethylacetate, petroleum ether, triethy-
lamine, CCK-8 [2H-tetrazolium, 5-(2,4-disulfophenyl)-3-
(2-methoxy-4-nitrophenyl)-2-(4-nitrophenyl) inner salt,
sodium salt (1:1)] were obtained from Energy Chemicals.
Column chromatography was carried out on silica gel (200–
300 mesh). Commercially available AR grade or chemically
pure reagents were used. Anhydrous solvents were dried and
redistilled prior to their use.
General procedure for the synthesis of Mannich base
derivatives 3–16
Compound 1 or 2 (200 mg, 0.78 mmol) was dissolved in
methanol (10 mL), then formaldehyde (0.94 mmol) and a
secondary amine (0.94 mmol) were introduced to this solu-
tion. The reaction mixture was stirred under microwave
irradiation (600 W) at 80 ◦C. The end of the reaction
was determined by TLC. When the reaction was com-
plete, the solvent was removed in vacuo. The residue was
extracted with ethyl acetate (3× 20mL) and water (15 mL).
The organic phases were combined, washed with H2O,
and dried over anhydrous sodium sulfate. The solvent was
evaporated and resulting crude material was purified by
silica gel column chromatography (ethyl acetate:petroleum
ether:triethylamine, v/v, 1:9:0.01) to obtain desired products
3–16.
(E)-3′-[(Dimethylamino)methyl]pterostilbene (3)
3 was obtained as yellow oil (169 mg, yield: 69 %).
1HNMR (400 MHz,CDCl3):δ 9.83(s, 1H,OH)7.23 (d, J =
8.2Hz, 1H, 6′-H), 7.03(s, 1H, 2′-H), 6.90 (d, J = 16.2Hz,
1H, β-CH=), 6.76(d, J= 16.2Hz, 1H, α-CH=), 6.73(d, J =
8.6Hz, 1H, 5′-H)., 6.54(s, 2H, 2-H and 6-H), 6.27 (s, 1H,4-
H), 3.71(s, 6H, 3-OCH3 and 5-OCH3), 3.55(s, 2H, 3′−CH2
N), 2.23(s, 6H,N(CH3)2);13 C NMR (100 MHz,CDCl3) :
δ161.0,158.3,139.9,129.0,128.3,127.3,126.7,125.8,122.1,
116.4, 104.3, 99.4, 62.8, 55.3, 44.4; ESIMSm/z:314 [M +
H]+.
(E)-3′-[(Diethylamino)methyl]pterostilbene (4)
4 was obtained as yellow oil (168 mg, yield 63 %).
1H NMR (400MHz, CDCl3): δ 7.22 (d, J = 8.3 Hz, 1H,
6′-H), 7.03 (s, 1H, 2′-H), 6.90 (d, J = 16.2 Hz, 1H, β-CH
=), 6.76 (d, J = 16.2 Hz, 1H, α-CH=), 6.70 (d, J = 8.3
Hz, 1H, 5′-H), 6.54(d, 2H, 2-H and 6-H), 6.27(s, 1H,4-H),
3.71 (s, 6H, 3-OCH3 and 5-OCH3), 3.68 (s, 2H, 3′-CH2N),
2.53(q, J = 6.8 Hz, 4H, 2CH2), 1.01 (t, J = 7.0 Hz, 6H,
123
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2CH3).13C NMR (100 MHz, CDCl3) : δ161.0, 158.6140.0,
129.1, 128.2, 127.0, 126.7, 125.6, 122.3, 116.4, 104.3,99.4,
56.9, 55.3, 46.3, 11.2; ESIMS m/z 342 [M+H]+.
(E)-3′-(Piperidin-1-ylmethyl)pterostilbene (5)
5 was obtained as white crystals (182mg, yield 66%),
m.p. 80−81 ◦C.1H NMR (400 MHz,CDCl3): δ 7.35 (d, J
= 7.6 Hz, 6′-H), 7.15 (s, 1H, 2′-H), 7.00(d, J = 16.2 Hz,
1H, β-CH=), 6.86 (d, J = 16.2 Hz, 1H, α-CH=), 6.82(s,
1H, 5′-H), 6.64 (s,2H, 2-H and 6-H), 6.37 (d, J = 2.1Hz,
1H, 4-H), 3.83 (s, 6H, 3-OCH3 and 5-OCH3), 3.73 (s, 2H,
3′-CH2N), 2.57 (t, J =2.3 Hz, 4H, NCH2), 1.69−1.65(m,
J =5.0Hz, 4H, 2CH2), 1.55−1.52 (m, J = 1.6Hz,2H,CH2);
13C NMR (100 MHz, CDCl3) : δ159.9, 157.2, 138.8, 128.0,
127.1, 126.0, 125.7, 124.6, 120.7, 115.3, 103.1, 98.3, 61.1,
54.3, 52.8, 24.8, 22.9; ESIMS m/z : 354 [M+H]+.
(E)-3′-[(4-Methylpiperazin-1-yl)methyl]pterostilbene (6)
6 was obtained as yellow oil (184 mg, yield 64 %).
1H NMR (400 MHz, CDCl3): δ7.26 (d, J = 8.3 Hz, 1H,
6′-H), 7.07 (s, 1H, 2′-H), 6.91(d, J =16.2 Hz, 1H,β-CH=),
6.82 (d, J =16.2 Hz, 1H, α-CH=), 6.74(d, J =7.9 Hz, 1H,
5′-H), 6.56 (s, 2H, 2-H and 6-H), 6.29 (s, 1H,4-H), 3.74 (s,
6H, 3-OCH3 and 5-OCH3), 3.66(s, 2H, 3′-CH2N), 2.80−2.27
(m, 8H, NCH2), 2.25 (s, 3H, NCH3); 13C NMR (100 MHz,
CDCl3) : δ159.9, 156.7, 138.7, 127.8, 127.5, 126.3, 125.9,
124.9, 120.2, 115.4, 103.2, 98.4, 60.3, 54.3, 53.8, 51.3,44.8;
ESIMS m/z: 369 [M+H]+.
(E)-3′-(Pyrrolidin-1-ylmethyl) pterostilbene (7)
7 was obtained as yellow oil (164 mg, yield 62 %).
1H NMR (400 MHz, CDCl3):δ 9.53 (s, 1H, OH), 7.35 (d, J
= 8.3, 1.8 Hz, 1H, 6′-H), 7.18 (d, J = 1.3 Hz, 1H, 2′-H),
7.02 (d, J = 16.2 Hz, 1H, β-CH=), 6.89 (d, J = 16.2 Hz,
1H, α-CH=), 6.85 (d, J = 8.4Hz, 1H, 5′-H), 6.66 (d, J =
2.1 Hz, 2H, 2-H and 6-H), 6.39 (d, J = 2.0 Hz, 1H, 4-H),
3.87 (d, J = 6.3 Hz, 2H, 3′-CH2N), 3.84(s, 6H, 3-OCH3
and 5-OCH3), 2.69 (s, 4H, N(CH2)2), 1.88 (s, 4H, 2CH2);
13C NMR (100 MHz, CDCl3):δ 160.8, 158.1, 139.8, 128.9,
128.1, 127.1, 126.3, 125.6, 122.3, 116.3, 104.1, 99.3, 58.5,
55.3, 53.4, 23.6;ESIMS m/z: 340 [M+H]+.
(E)-3′, 5′-Bis[(4-methylpiperazin-1-yl)methyl]
pterostilbene (8)
8 was obtained as yellow oil (131 mg, yield 35 %).
1H NMR (400 MHz, CDCl3):δ 7.18 (s, 2H, 2′-H and 6′-H),
6.96 (d, J = 16.2 Hz, 1H, β-CH=), 6.83 (d, J = 16.2 Hz,
1H, α-CH=), 6.60 (d, J = 1.9 Hz, 2H, 2-H and 6-H), 6.32
(d, J =1.7 Hz, 1H, 4-H), 3.78(s, 6H, 3-OCH3 and5-OCH3),
3.62(d, J = 4.3 Hz, 4H, 3′-CH2N and 5′-CH2N), 2.89−
2.27 (m, 16H, NCH2), 2.25 (s, 6H, NCH3);13 C NMR (100




9 was obtained as yellow oil (117 mg, yield 33 %).
1H NMR (400 MHz, CDCl3):δ 7.17 (s, 2H, 2′-H and 6′-H),
6.92 (d, J = 16.2 Hz,1H, β-CH=), 6.80 (d, J = 16.2 Hz,
1H, α-CH=), 6.56 (s, 2H, 2-H and 6-H), 6.29 (s, 1H, 4-H),
3.74 (s, 6H, 3-OCH3 and 5-OCH3), 3.67(s, 8H,OCH2),3.58
(s, 4H, 3′-CH2N and 5′-CH2N), 2.49 (s, 8H, NCH2); 13C
NMR (100 MHz, CDCl3) : δ161.0, 156.2, 139.7, 128.8,
128.1, 127.7, 126.1, 122.3, 104.3, 99.5, 66.8, 59.3, 55.4,
53.2;ESIMS m/z: 455 [M+H]+.
(E)-3′-Methoxyl-5′-((dimethylamino)methyl)pterostilbene
(10)
10 was obtained as yellow oil (173 mg, yield 72 %).
1H NMR (400 MHz, CDCl3): δ 8.63 (s, 1H, OH), 6.99 (s,
1H, 6′-H), 6.97 (d, J =16.2 Hz, 1H, β-CH=), 6.86 (d, J =
16.2Hz, 1H, α-CH=), 6.75 (s, 1H, 2′-H), 6.64 (d, J = 2.1
Hz, 2H, 2-H and 6-H), 6.36 (d, J = 2.1 Hz, 1H, 4-H), 3.93
(s, 3H, 3′-OCH3), 3.81 (s, 6H, 3-OCH3 and 5-OCH3), 3.66
(s, 2H, 5′-CH2N), 2.34(s, 6H, NCH3);13 C NMR (100MHz,
CDCl3) : δ 160.8, 148.0, 147.6, 139.6, 129.1, 127.9, 125.8,
121.9, 119.4, 108.7, 104.1, 99.4, 62.5, 55.8, 55.2, 44.4;
EIMS m/z: 343 [M]+.
(E)-3′-Methoxyl-5′- ((diethylamino)methyl) pterostilbene
(11)
11 was obtained as yellow oil (189 mg, yield 73 %).
1H NMR (400 MHz, CDCl3) : δ 6.90 (s, 1H, 6′-C), 6.89(d,
J = 16.2 Hz, β-CH=), 6.78 (d, 1H, J = 16.2 Hz, α-CH=),
6.67 (s, 1H, 2′-H), 6.56(d, J = 2.1 Hz, 2H, 2-H and 6-H),
6.29(t, J = 2.1 Hz, 1H,4-H), 3.85 (s, 3H, 3′ -OCH3), 3.74
(s, 6H, 3-OCH3 and 5-OCH3), 3.71 (s, 2H, 5′-CH2N), 2.56
(q, J =6.1 Hz, 4H, NCH2), 1.04 (t, J =6.2 Hz, 6H, 2CH3);
13C NMR (100 MHz, CDCl3) :δ160.8, 148.4, 147.9, 139.6,
129.4, 127.8, 125.8, 121.5, 119.6, 108.4, 104.1, 99.4, 56.0,
55.7, 55.2, 46.2, 11.0; EIMS m/z : 371 [M]+.
(E)-3′-Methoxyl-5′-(piperidin-1-yl methyl) pterostilbene
(12)
12 was obtained as yellow oil (185 mg, yield 69 %).
1H NMR (400 MHz, CDCl3):δ 6.90 (s, 1H, 6′-H), 6.89 (d,
J = 16.2 Hz, β-CH=), 6.77 (d, J = 16.2 Hz, 1H, α-CH=),
6.65 (d, J = 1.5 Hz, 1H, 2′-H), 6.56 (d, J = 2.2 Hz, 2H,
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2-H and 6-H), 6.28 (d, J = 2.2 Hz, 1H, 4-H), 3.84 (s, 3H,
3′-OCH3), 3.72 (s, 6H, 3-OCH3 and 5-OCH3), 3.59 (s, 2H,
5′-CH2N), 2.60− 2.26 (m, 4H,NCH2), 1.59−1.52 (m, 4H,
CH2), 1.40 (s, 2H, CH2); 13C NMR (100 MHz,CDCl3) :
δ 160.8, 147.9, 147.6, 139.6, 129.6, 127.7, 125.6, 121.4,
119.4, 108.4, 104.0, 99.3, 61.8, 55.7, 55.4, 537, 25.7, 23.8;
EIMS m/z: 383 [M]+.
(E)-3′-Methoxyl-5′-[(4-methylpiperazin-1-yl)methyl]
pterostilbene (13)
13 was obtained as yellow oil (173 mg, yield 62 %).
1H NMR (400 MHz, CDCl3):δ 6.99(s, 1H, 6′-H), 6.98 (d,
J = 16.2 Hz, 1H, β-CH=), 6.86 (d, J = 16.2 Hz, 1H,
α-CH=), 6.78 (d, J = 1.4 Hz, 1H, 2′-H), 6.64 (d, J =
2.2 Hz, 2H, 2-H and 6-H), 6.37 (t, J = 2.2 Hz, 1H, 4-H),
3.94 (s, 3H, 3′-OCH3), 3.83 (s, 6H, 3-OCH3 and 5-OCH3),
3.75 (s, 2H, 5′-CH2N), 2.88−2.35 (m, 8H, NCH2), 2.32 (s,
3H, NCH3);13 C NMR (100 MHz, CDCl3) : δ 160.9, 148.1,
147.2, 139.7, 129.1, 128.2, 126.1, 121.1, 119.6, 108.7,




14 was obtained as yellow oil (173 mg, yield 67 %).
1H NMR (400 MHz, CDCl3) : δ 6.90 (s, 1H, 6′-H), 6.89(d,
J = 16.2 Hz, β-CH=), 6.78 (d, J = 16.2 Hz, 1H, α
-CH=), 6.68 (s, 1H, 2′-H), 6.56 (d, J = 2.1 Hz, 2H, 2-H
and 6-H), 6.29 (s, 1H, 4-H), 3.85 (s, 3H, 3′-OCH3), 3.77
(s, 2H, 5′-CH2N), 3.74 (s, 6H, 3-OCH3and 5-OCH3), 2.66
−2.49 (m, 4H, NCH2), 1.79−1.74 (m, 4H, CH2);13 C NMR
(100MHz, CDCl3) : δ 159.9, 147.1, 146.5, 138.7, 128.2,
127.1, 125.0, 120.4, 118.6, 107.7, 103.3, 98.5, 60.2, 55.0,
54.3, 49.1, 33.0; EIMS m/z: 369[M]+.
(E)-3′-Methoxyl-5′-(morpholinomethyl)pterostilbene (15)
15 was obtained as yellow oil (199 mg, yield 74 %).
1H NMR (400 MHz, CDCl3): δ 6.91(s, 1H, 6′-H)6.90 (d,
J = 16.2 Hz, 1H, β-CH=), 6.79 (d, J = 16.2 Hz, 1H, α
-CH=), 6.69 (s, 1H, 2′-H), 6.56(d, J = 2.1 Hz, 2H, 2-H
and 6-H), 6.29 (t, J = 2.1 Hz, 1H, 4-H), 3.85 (s, 3H, 3′
-OCH3), 3.74 (s, 6H, 3-OCH3 and 5-OCH3), 3.68 (s, 2H, 5′
-CH2N), 3.67 (t, J = 4.2 Hz, 4H,NCH2), 2.52 (s, 4H,
OCH2).13C NMR (100 MHz, CDCl3) : δ 160.9, 148.0,
146.9, 139.5, 129.0, 128.4, 126.1, 120.7, 119.7, 108.8,104.2,
99.5, 66.7, 61.5, 55.8, 55.1, 52.8; EIMS m/z : 385 [M]+.
(E)-3′-Methoxyl-5′-(piperidin-4-ol-1-ylmethyl)
pterostilbene (16)
16 was obtained as yellow oil (170 mg, yield 61 %).
1H NMR (400 MHz, CDCl3):δ 6.98(d, J = 16.2, Hz,1H,
β-CH=), 6.97(s, 1H, 6′-H), 6.86 (d, J = 16.2 Hz, 1H,
α-CH=), 6.75 (d, J = 1.2 Hz, 1H, 2′-H), 6.64 (d, J =
2.2 Hz, 2H, 2-H and 6-H), 6.37 (t, J = 2.1 Hz, 1H,4-H),
3.93 (s, 3H, 3′-OCH3), 3.82 (s, 6H, 3-OCH3 and 5-OCH3),
3.72 (s, 2H, 5′-CH2N), 3.68−3.65(m, 1H, CH-O), 2.86−
2.37 (m, 4H, NCH2), 1.93−1.60 (m, 4H, 2CH2);13 C NMR
(100 MHz, CDCl3) : δ 160.8, 147.9, 147.4, 139.6, 129.4,
127.9, 125.8, 122.0, 119.2, 108.3, 104.1, 99.4, 58.0, 55.8,
55.2, 53.3, 29.8, 23.5; EIMS m/z : 399[M]+.
Assay for antiproliferative activity
The CCK-8 reagent solution (10%, 10µL) was added to
eachwell of a 96-wellmicrotiter plate containing 5×103 cells
(Hela), then different concentrations of compounds 1–16
(100, 25, 6.25, 1.56, 0.39, 0.0976, 0.0244, 0.0061µM)were
added and incubated for 48 h [18]. Absorbancewasmeasured
at 450 ∼ 490 nm using a microplate reader. A dose-response
curve was plotted for each compound, and the half maxi-
mal inhibitory concentration (IC50) for cancer cell lines was
recorded.
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